RCSB PDB - 3N0N: Crystal structure of human carbonic anhydrase II in complex with a benzenesulfonamide inhibitor (original) (raw)
Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency.
[Pacchiano, F.](/search?q=citation.rcsb%5Fauthors:Pacchiano, F.), [Aggarwal, M.](/search?q=citation.rcsb%5Fauthors:Aggarwal, M.), [Avvaru, B.S.](/search?q=citation.rcsb%5Fauthors:Avvaru, B.S.), [Robbins, A.H.](/search?q=citation.rcsb%5Fauthors:Robbins, A.H.), [Scozzafava, A.](/search?q=citation.rcsb%5Fauthors:Scozzafava, A.), [McKenna, R.](/search?q=citation.rcsb%5Fauthors:McKenna, R.), [Supuran, C.T.](/search?q=citation.rcsb%5Fauthors:Supuran, C.T.)
(2010) Chem Commun (Camb) 46: 8371-8373
PubMed: 20922253 Search on PubMed
PubMed Abstract:
4-Substituted-ureido benzenesulfonamides showing inhibitory activity against carbonic anhydrase (CA, EC 4.2.1.1) II between 3.3-226 nM were crystallized in complex with the enzyme. Hydrophobic interactions between the scaffold of the inhibitors in different hydrophobic pockets of the enzyme were observed, explaining the diverse inhibitory range of these derivatives.
Organizational Affiliation:
Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Box 100245, Gainesville, Florida 32610, USA.